Comparing Artificial Intelligence for Assisted Diagnosis of Diabetic Retinopathy
NCT ID: NCT06423274
Last Updated: 2024-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
1000 participants
OBSERVATIONAL
2024-07-10
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Artificial Intelligence System for Assessing Image Quality of Fundus Images and Its Effects on Diagnosis
NCT04289064
Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening
NCT03911323
Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph
NCT04723160
Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application
NCT03899623
Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care
NCT07236879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study was conducted as a prospective study. Participants meeting eligibility criteria will be recruited from sites staffed by trained photographers. After assessing eligibility and obtaining informed consent, fundus photographs will be taken using a non-dilated fundus camera. And optical coherence tomography or fundus fluorescence angiography will be performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
artificial intelligence-assisted fundus photography
Artificial intelligence-assisted fundus photography in patients with diabetic retinopathy
fundus photography
using artificial intelligence to identify diabetic retinopathy using fundus photography
optical coherence tomography
optical coherence tomography in patients with diabetic retinopathy
optical coherence tomography
detect diabetic retinopathy and diabetic macular edema by optical coherence tomography
fundus fluorescence angiography
fundus fluorescence angiography in patients with diabetic retinopathy
fundus fluorescence angiography
detect diabetic retinopathy by fundus fluorescence angiography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fundus photography
using artificial intelligence to identify diabetic retinopathy using fundus photography
optical coherence tomography
detect diabetic retinopathy and diabetic macular edema by optical coherence tomography
fundus fluorescence angiography
detect diabetic retinopathy by fundus fluorescence angiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Obtaining informed consent;
3. Patient age 18 or above.
Exclusion Criteria
2. Failure to Obtain informed consent;
3. Presence of other retinal diseases;
4. A patient who has already undergone the treatment.
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wu Hongkang
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DR artificial intelligence
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.